中国医药流通业的现状及发展策略  

Present Situation and Developing Strategy of the Pharmaceutical Circulation Enterprises in China

作　　者：马爱霞[1] 黄艳[1] 汤晶晶[1] 王婧[1] 韩健[1] 

机构地区：[1]中国药科大学,南京市210009

出　　处：《中国药房》2004年第1期11-13,共3页China Pharmacy

摘　　要：目的 :提升我国医药流通企业的竞争力 ,使之更好地适应WTO规则 ,以构建一条安全、高效、便捷的药品流通之路。方法 :走访全国22个省市的医药相关部门和企业 ,收集第一手资料 ;并查阅了大量文献。结果与结论 :政府应加强宏观管理 ,构建公平、统一、有序的全国市场 ;企业要“做大”、“做强” ,提高核心竞争力 ;行业协会应切实发挥微观协调作用。OBJECTIVE:To raise the competition power of China's pharmaceutical enterprises,make them adapt to the principle of WTO better,and finally to build a safe,effective,and convenient pharmaceutical circulation channel.METHODS:To interview the pharmacy-related departments and enterprises in22provinces and cities to collect the firsthand materials,and consult a lot of literature.RESULTS&CONCLUSION:The government should enhance the macro-management for the purpose to build a fair,unified and ordered national market;enterprise should promote and enhance themselves to improve the core competition capacity;the trade association should play a role in micro-harmonization.

关 键 词：医药流通业 现状 问题 建议 

分 类 号：F713[经济管理—产业经济]